Our team has developed Apollo 1060, a patent-pending AI-augmented decision-making platform for small molecule drug discovery that can rapidly search a chemical space that is orders of magnitude larger than existing methods. Our purpose at 99andBeyond is to develop and provide access to transformative new precision medicines to extend the healthspan of one billion people by 2050.